\-\ Texto\\:\\ \ \(0\)\
\-\ left\\ lateral\\ hepatic\\ lobe\\ mass\\ shows\\ peripheral\\ nodular\\ enhancement\\ on\\ arterial\\ phase\\ imaging\\.\\ \\ on\\ delayed\\ imaging\\,\\ continual\\ filling\\ in\\ of\\ this\\ mass\\ with\\ contrast\\ is\\ seen\\.\ \(0\)\
\-\ cavernous\\ hemangioma\ \(14\)\
\-\ ddx\\ for\\ enhancing\\ focal\\ liver\\ lesions\\:\ \(0\)\
\-\ cavernous\\ hemangioma\ \(14\)\
\-\ focal\\ nodular\\ hyperplasia\ \(9\)\
\-\ adenoma\ \(519\)\
\-\ hepatocellular\\ carcinoma\ \(28\)\
\-\ metastases\ \(207\)\
\-\ 30\\ year\\ old\\ male\\ presents\\ with\\ hematuria\\.\ \(1\)\
\-\ diagnosis\\ of\\ hepatic\\ hemangioma\\ can\\ be\\ made\\ on\\ the\\ basis\\ of\\ a\\ characteristic\\ peripheral\\ nodular\\ enhancement\\ with\\ gradual\\ fill\\-in\\,\\ mirroring\\ the\\ density\\ of\\ the\\ blood\\ pool\\.\\ focal\\ nodular\\ hyperplasia\\ is\\ the\\ second\\ most\\ common\\ benign\\ hepatic\\ neoplasm\\.\\ \\ fnh\\ is\\ a\\ hypervascular\\,\\ well\\-marginated\\ tumor\\ that\\ often\\ contains\\ a\\ characteristic\\ stellate\\ central\\ scar\\.\\ \\ most\\ often\\,\\ fnh\\ shows\\ intense\\ early\\ arterial\\ phase\\ enhancement\\,\\ but\\ is\\ often\\ imperceptible\\ during\\ later\\ phases\\ as\\ the\\ tumor\\ parenchymal\\ attenuation\\ matches\\ normal\\ enhancing\\ hepatic\\ parenchyma\\.\\ \ \(0\)\
\-\ adenomas\\ are\\ also\\ hypervascular\\ lesions\\ that\\ can\\ have\\ a\\ variable\\ appearance\\ on\\ ct\\ due\\ to\\ its\\ propensity\\ to\\ hemorrhage\\.\\ \\ typically\\,\\ areas\\ of\\ infarction\\ and\\ hemorrhage\\ are\\ present\\ and\\ may\\ make\\ them\\ difficult\\ to\\ distinguish\\ from\\ hepatocellular\\ carcinoma\\.\\ hepatic\\ adenomas\\ also\\ tend\\ to\\ enhance\\ early\\ during\\ arterial\\ phase\\ in\\ a\\ heterogenous\\ fashion\\.\ \(0\)\
\-\ while\\ both\\ are\\ variable\\ in\\ their\\ phase\\ of\\ enhancement\\ and\\ washout\\ characteristics\\,\\ neither\\ hepatocellular\\ carcinoma\\ nor\\ metastases\\ will\\ demonstrate\\ the\\ specific\\ enhancement\\ pattern\\ described\\ above\\ and\\ demonstrated\\ in\\ this\\ case\\ and\\ should\\ not\\ be\\ realistically\\ considered\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hepatic\\:\\ 0\\.07657713201300455\ \(0\)\
\-\ phase\\:\\ 0\\.06900820392051085\ \(0\)\
\-\ hepatocellular\\:\\ 0\\.06339525483934598\ \(0\)\
\-\ nodular\\:\\ 0\\.061534932310934105\ \(0\)\
\-\ fnh\\:\\ 0\\.05434001522899998\ \(0\)\
\-\ hemangioma\\:\\ 0\\.049162740131361155\ \(0\)\
\-\ enhancement\\:\\ 0\\.04915211944470034\ \(0\)\
\-\ adenomas\\:\\ 0\\.04875557260117896\ \(0\)\
\-\ arterial\\:\\ 0\\.04815894346007731\ \(0\)\
\-\ hypervascular\\:\\ 0\\.04338470650878056\ \(0\)\
\-\ variable\\:\\ 0\\.03908015920107453\ \(0\)\
\-\ mirroring\\:\\ 0\\.03783484302131544\ \(0\)\
\-\ realistically\\:\\ 0\\.03783484302131544\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.03614032822299061\ \(0\)\
\-\ often\\:\\ 0\\.03510480963759209\ \(0\)\
\-\ cavernous\\:\\ 0\\.034021357596968935\ \(0\)\
\-\ matches\\:\\ 0\\.033119768821023125\ \(0\)\
\-\ continual\\:\\ 0\\.031885081814792306\ \(0\)\
\-\ focal\\:\\ 0\\.03142266443096655\ \(0\)\
\-\ metastases\\:\\ 0\\.031336759227836776\ \(0\)\
\-\ carcinoma\\:\\ 0\\.031183618068873816\ \(0\)\
\-\ characteristic\\:\\ 0\\.03104739392876114\ \(0\)\
\-\ fill\\-in\\:\\ 0\\.030927384169666942\ \(0\)\
\-\ imperceptible\\:\\ 0\\.030927384169666942\ \(0\)\
\-\ propensity\\:\\ 0\\.029483297317215384\ \(0\)\
\-\ well\\-marginated\\:\\ 0\\.028910201211530737\ \(0\)\
\-\ stellate\\:\\ 0\\.027543447000721578\ \(0\)\
\-\ early\\:\\ 0\\.02682539888105097\ \(0\)\
\-\ peripheral\\:\\ 0\\.02654020018896238\ \(0\)\
\-\ washout\\:\\ 0\\.025429814017469243\ \(0\)\
\-\ neither\\:\\ 0\\.02456856639746001\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.02441421960666125\ \(0\)\
\-\ fashion\\:\\ 0\\.02419512701123842\ \(0\)\
\-\ phases\\:\\ 0\\.024019925318018442\ \(0\)\
\-\ gradual\\:\\ 0\\.023533536110692248\ \(0\)\
\-\ enhancing\\:\\ 0\\.023003892986135272\ \(0\)\
\-\ them\\:\\ 0\\.022454933414207675\ \(0\)\
\-\ during\\:\\ 0\\.022446431329818096\ \(0\)\
\-\ distinguish\\:\\ 0\\.022337341250310186\ \(0\)\
\-\ basis\\:\\ 0\\.022002742359882237\ \(0\)\
\-\ pool\\:\\ 0\\.02149723576908231\ \(0\)\
\-\ tend\\:\\ 0\\.0207949635640102\ \(0\)\
\-\ shows\\:\\ 0\\.02016629785175003\ \(0\)\
\-\ lesions\\:\\ 0\\.019635712500806417\ \(0\)\
\-\ contains\\:\\ 0\\.019600957862305316\ \(0\)\
\-\ make\\:\\ 0\\.019600957862305316\ \(0\)\
\-\ nor\\:\\ 0\\.019600957862305316\ \(0\)\
\-\ intense\\:\\ 0\\.01942085400351119\ \(0\)\
\-\ ddx\\:\\ 0\\.019362460647048618\ \(0\)\
\-\ scar\\:\\ 0\\.019136521876724922\ \(0\)\
\-\ heterogenous\\:\\ 0\\.01881846191039993\ \(0\)\
\-\ characteristics\\:\\ 0\\.018245365804715287\ \(0\)\
\-\ parenchymal\\:\\ 0\\.018027458828863686\ \(0\)\
\-\ enhance\\:\\ 0\\.017739859213915358\ \(0\)\
\-\ hematuria\\:\\ 0\\.017396328279694173\ \(0\)\
\-\ imaging\\:\\ 0\\.017185183042537362\ \(0\)\
\-\ tumor\\:\\ 0\\.017100706451594946\ \(0\)\
\-\ most\\:\\ 0\\.0169342072251337\ \(0\)\
\-\ can\\:\\ 0\\.01663710173793193\ \(0\)\
\-\ difficult\\:\\ 0\\.016052981153359104\ \(0\)\
\-\ their\\:\\ 0\\.016052981153359104\ \(0\)\
\-\ parenchyma\\:\\ 0\\.015619608117565104\ \(0\)\
\-\ described\\:\\ 0\\.015619608117565104\ \(0\)\
\-\ adenoma\\:\\ 0\\.015315426402600911\ \(0\)\
\-\ specific\\:\\ 0\\.015160148906560127\ \(0\)\
\-\ are\\:\\ 0\\.01499837604115367\ \(0\)\
\-\ infarction\\:\\ 0\\.014989306630163476\ \(0\)\
\-\ delayed\\:\\ 0\\.014926954267232532\ \(0\)\
\-\ considered\\:\\ 0\\.014804903042680888\ \(0\)\
\-\ filling\\:\\ 0\\.01476497861065379\ \(0\)\
\-\ attenuation\\:\\ 0\\.014745154808695444\ \(0\)\
\-\ made\\:\\ 0\\.014608894300907546\ \(0\)\
\-\ also\\:\\ 0\\.014460254022919753\ \(0\)\
\-\ 30\\:\\ 0\\.014103387710107617\ \(0\)\
\-\ second\\:\\ 0\\.014086390279995614\ \(0\)\
\-\ pattern\\:\\ 0\\.01401906583292394\ \(0\)\
\-\ its\\:\\ 0\\.013839190744444813\ \(0\)\
\-\ above\\:\\ 0\\.013441796809561445\ \(0\)\
\-\ later\\:\\ 0\\.013242140090098385\ \(0\)\
\-\ typically\\:\\ 0\\.012946033345519194\ \(0\)\
\-\ that\\:\\ 0\\.012669362476899771\ \(0\)\
\-\ benign\\:\\ 0\\.01265686852803949\ \(0\)\
\-\ liver\\:\\ 0\\.012644727514303535\ \(0\)\
\-\ neoplasm\\:\\ 0\\.012489942385888103\ \(0\)\
\-\ on\\:\\ 0\\.012427313517003057\ \(0\)\
\-\ areas\\:\\ 0\\.012340545799339343\ \(0\)\
\-\ density\\:\\ 0\\.01206708736849768\ \(0\)\
\-\ central\\:\\ 0\\.01206708736849768\ \(0\)\
\-\ should\\:\\ 0\\.011691882154029184\ \(0\)\
\-\ while\\:\\ 0\\.011539267123829671\ \(0\)\
\-\ will\\:\\ 0\\.011474167460854686\ \(0\)\
\-\ be\\:\\ 0\\.01131121650938995\ \(0\)\
\-\ demonstrated\\:\\ 0\\.010761459152175825\ \(0\)\
\-\ appearance\\:\\ 0\\.010488869428045671\ \(0\)\
\-\ mass\\:\\ 0\\.010201382033884675\ \(0\)\
\-\ blood\\:\\ 0\\.010010347950683689\ \(0\)\
\-\ lobe\\:\\ 0\\.00986834913271903\ \(0\)\
\-\ due\\:\\ 0\\.00978659722297356\ \(0\)\
\-\ is\\:\\ 0\\.009653060573128336\ \(0\)\
\-\ common\\:\\ 0\\.009597713356036038\ \(0\)\
\-\ both\\:\\ 0\\.009365665196077774\ \(0\)\
\-\ a\\:\\ 0\\.008510725360914191\ \(0\)\
\-\ demonstrate\\:\\ 0\\.00843970876108601\ \(0\)\
\-\ diagnosis\\:\\ 0\\.008421542192190642\ \(0\)\
\-\ present\\:\\ 0\\.008283299373097342\ \(0\)\
\-\ this\\:\\ 0\\.008250104835314447\ \(0\)\
\-\ contrast\\:\\ 0\\.008209337711621911\ \(0\)\
\-\ \\,\\:\\ 0\\.008132920423266144\ \(0\)\
\-\ may\\:\\ 0\\.008044327763511262\ \(0\)\
\-\ case\\:\\ 0\\.008023624175396012\ \(0\)\
\-\ have\\:\\ 0\\.007941794327747175\ \(0\)\
\-\ lateral\\:\\ 0\\.0079256139297191\ \(0\)\
\-\ but\\:\\ 0\\.00782190257954308\ \(0\)\
\-\ presents\\:\\ 0\\.007492035603038309\ \(0\)\
\-\ to\\:\\ 0\\.007331641346660709\ \(0\)\
\-\ seen\\:\\ 0\\.007247328820033005\ \(0\)\
\-\ in\\:\\ 0\\.007234287212708239\ \(0\)\
\-\ male\\:\\ 0\\.006631783424409756\ \(0\)\
\-\ normal\\:\\ 0\\.005749409676390991\ \(0\)\
\-\ as\\:\\ 0\\.005547542943751621\ \(0\)\
\-\ from\\:\\ 0\\.005435346408387177\ \(0\)\
\-\ not\\:\\ 0\\.005299650951682126\ \(0\)\
\-\ ct\\:\\ 0\\.0051300585982491115\ \(0\)\
\-\ \\:\\:\\ 0\\.004850964875496417\ \(0\)\
\-\ left\\:\\ 0\\.004103456091300063\ \(0\)\
\-\ year\\:\\ 0\\.004103456091300063\ \(0\)\
\-\ and\\:\\ 0\\.0038628542002621985\ \(0\)\
\-\ old\\:\\ 0\\.0037550841067049553\ \(0\)\
\-\ the\\:\\ 0\\.00356006741726075\ \(0\)\
\-\ for\\:\\ 0\\.0031292195220717386\ \(0\)\
\-\ of\\:\\ 0\\.0030000978746263117\ \(0\)\
\-\ \\.\\:\\ 0\\.0016759437642523993\ \(0\)\
\-\ with\\:\\ 0\\.0015064915376380654\ \(0\)\
